Gene signature found for poor response to standard chemotherapy in rare uterine cancer
(Medical College of Georgia at Augusta University) Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Chemotherapy | Genetics | Georgia Health | International Medicine & Public Health | Serous Carcinoma | Women